Cordeiro NM

No ORCID on file · 2 papers in corpus
article 2022
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph15111414

BACKGROUND: Current drugs for the treatment of endometriosis are not able to completely cure the condition, and significant side effects hinder the continuation of treatment. Therefore, it is necessary to search for new drug candidates. In …

2016
PloS one ·doi:10.1371/journal.pone.0156271

LASSBio-1524 was designed as inhibitor of the IKK-β (kappa β kinase inhibitor) enzyme, which participates in the activation of the nuclear factor κB (NF-κB) canonical pathway, and its three N-acylhydrazone new analogues, LASSBio-1760, LASSB…